If you typed Avanti Pesquisa Clínica into a search box, you are probably building a CRO shortlist. This article uses only what Avanti Pesquisa Clínica publishes (avantipc.com.br/en) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.
What Avanti Pesquisa Clínica publishes
Avanti Pesquisa Clínica is a São Paulo ARO/CRO that serves pharmaceutical, biotechnology, biosimilar and medical device companies across Phases I–IV, with clinical supplies and device storage among its services. We found no named device study on its site.
Avanti Pesquisa Clínica vs bioaccess®
| Dimension | Avanti Pesquisa Clínica | bioaccess® |
|---|---|---|
| Core focus | Brazil ARO/CRO + clinical supplies | First-in-human and early feasibility studies for medical devices |
| Geography | See provider site | Latin America, since 2010 |
| Device FIH track record | No named device first-in-human study found on the public pages reviewed | Published case studies on bioaccessla.com |
| After the trial | See provider site | Live multi-country sanitary registration and in-country holder service |
Where each one fits
If you need a Brazilian partner for study execution plus clinical-supply logistics, Avanti covers both.
If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO on your list, including Avanti Pesquisa Clínica, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.
Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.
Ready to compare a proposal? Request a first-in-human study proposal.
Competitor facts from the Avanti Pesquisa Clínica public pages linked above and public announcements, reviewed for bioaccess® competitive research (Aug–Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.
Leave a Reply